コンテンツへスキップ
Merck

Extensive genetics of ALS: a population-based study in Italy.

Neurology (2012-10-27)
Adriano Chiò, Andrea Calvo, Letizia Mazzini, Roberto Cantello, Gabriele Mora, Cristina Moglia, Lucia Corrado, Sandra D'Alfonso, Elisa Majounie, Alan Renton, Fabrizio Pisano, Irene Ossola, Maura Brunetti, Bryan J Traynor, Gabriella Restagno
要旨

To assess the frequency and clinical characteristics of patients with mutations of major amyotrophic lateral sclerosis (ALS) genes in a prospectively ascertained, population-based epidemiologic series of cases. The study population includes all ALS cases diagnosed in Piemonte, Italy, from January 2007 to June 2011. Mutations of SOD1, TARDBP, ANG, FUS, OPTN, and C9ORF72 have been assessed. Out of the 475 patients included in the study, 51 (10.7%) carried a mutation of an ALS-related gene (C9ORF72, 32; SOD1, 10; TARDBP, 7; FUS, 1; OPTN, 1; ANG, none). A positive family history for ALS or frontotemporal dementia (FTD) was found in 46 (9.7%) patients. Thirty-one (67.4%) of the 46 familial cases and 20 (4.7%) of the 429 sporadic cases had a genetic mutation. According to logistic regression modeling, besides a positive family history for ALS or FTD, the chance to carry a genetic mutation was related to the presence of comorbid FTD (odds ratio 3.5; p = 0.001), and age at onset ≤54 years (odds ratio 1.79; p = 0.012). We have found that ∼11% of patients with ALS carry a genetic mutation, with C9ORF72 being the commonest genetic alteration. Comorbid FTD or a young age at onset are strong indicators of a possible genetic origin of the disease.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
リボヌクレアーゼA ウシ膵臓由来, Type I-A, powder, ≥60% RNase A basis (SDS-PAGE), ≥50 Kunitz units/mg protein
Sigma-Aldrich
リボヌクレアーゼA ウシ膵臓由来, for molecular biology, ≥70 Kunitz units/mg protein, lyophilized
Sigma-Aldrich
リボヌクレアーゼA ウシ膵臓由来, Type III-A, ≥85% RNase A basis (SDS-PAGE), 85-140 Kunitz units/mg protein
Sigma-Aldrich
リボヌクレアーゼA ウシ膵臓由来, (Solution of 50% glycerol, 10mM Tris-HCL pH 8.0)
Sigma-Aldrich
リボヌクレアーゼA ウシ膵臓由来, Type I-AS, 50-100 Kunitz units/mg protein
Sigma-Aldrich
リボヌクレアーゼA ウシ膵臓由来, Type XII-A, ≥90% (SDS-PAGE), 75-125 Kunitz units/mg protein
Sigma-Aldrich
リボヌクレアーゼB ウシ膵臓由来, BioReagent, ≥50 Kunitz units/mg protein, ≥80% (SDS-PAGE)
Sigma-Aldrich
リボヌクレアーゼA ウシ膵臓由来, Type II-A, ≥60% (SDS-PAGE), >= 60 Kunitz units/mg protein
Sigma-Aldrich
リボヌクレアーゼA ウシ膵臓由来, Type X-A, ≥90% (SDS-PAGE), ≥70 Kunitz units/mg protein